Good ones, bad ones, we take them all right here.
With new EcoMin Maehara attending the policy meeting (first to do so in ten years), maybe something ‘is’ in the works?
Good ones, bad ones, we take them all right here.
With new EcoMin Maehara attending the policy meeting (first to do so in ten years), maybe something ‘is’ in the works?
Most Popular
Sponsored
UNH shows strong revenue growth & returns at 19.6x P/E. QRHC faces sales decline & high debt.
DDOG's 27.6% ARR growth & 80% gross margin vs. 11.9x P/S. COHR's 25.9% sales growth vs. 47.3x P/E. CRC's 16.9% revenue growth vs. 13x P/E.
ORN, AMN, QCRH show weak sales/EPS, high P/E. Avoid these small caps; seek high-growth alternatives.
GIII, ADT, WU show slow growth & shrinking margins. Valuations at 14.7x, 7.8x, 4.7x P/E may not justify risks.
ACN & BRO show strong growth (9.6%, 11.6%) & FCF margins (17.3%, 22.3%) at 12.6x & 13.5x P/E. WFRD struggles with sales (-5.1%) at 18.6x P/E.
DOCN's 9.9x P/S & 59.9% gross margin raise red flags. GFF's 16.9x P/E & WOR's 14.4x P/E signal risks.
Value stocks offer safety, but beware of traps. MAT, BWIN, ACM trade low P/E but show weak growth & cash flow.
Sponsored
Must Read